Choline alphoserate | Cholitilin Capsules 400 mg 28 pcs.

Pharmacological action

Nootropic.

Indications

In complex therapy for:

traumatic brain injury with a predominantly stem level lesion (acute period)

cerebrovascular insufficiency

psycho-organic syndrome against the background of degenerative diseases and involutional processes of the brain

multi-infarct dementia.

Contraindications

Hypersensitivity, hemorrhagic stroke (acute stage), pregnancy, lactation, children under 18 years of age.

Use during pregnancy and lactation

Contraindicated in pregnancy, during lactation.

Special instructions

During the treatment period, care must be taken when driving and engaging in other potentially dangerous activities, requiring increased concentration of attention and speed of psychomotor reactions.

Dosage and administration

Inside, 0.4 g 3 times a day, for 3-6 months.

In the subacute TBI period, 0.8 g in the morning and 0.4 g in the afternoon for 6 months.

Side effects

From the digestive system: gastritis, gastric ulcer, pharyngitis.

From the nervous system: nervousness, cerebral ischemia, cramps, hyperkinesia, dizziness.

Other: allergic reactions, increased urination.

Drug Interactions

Drug Interactions Cholitilin not established.

Storage Conditions

In a dry, dark place at a temperature not exceeding 25 РC.

Keep out of the reach and sight of children.

Expiration

2 years.

Terms leave through pharmacies

In retseptu

Dosage form

capsule

Kanonfarma, Russia